Scilex Holding (SCLX) Operating Leases (2021 - 2026)
Scilex Holding (SCLX) recorded quarterly Operating Leases of $12.7 million in Q1 2026, down 3.54% quarter-over-quarter from $13.2 million in Q4 2025, and up 855.99% on a YoY basis from $1.3 million in Q1 2025.
Scilex Holding (SCLX) Operating Leases (2021 - 2026) Analysis & Trends
Scilex Holding's Operating Leases history runs 6 years deep, the most recent figure standing at $12.7 million for Q1 2026.
- In Q1 2026, Operating Leases rose 855.99% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (up 855.99% YoY), while the FY2025 annual figure was $13.2 million, up 763.49% from the prior year.
- Operating Leases was $12.7 million for Q1 2026 at Scilex Holding, down from $13.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $13.2 million in Q4 2025 to a low of $461000.0 in Q1 2023.
- Historically, Operating Leases has averaged $3.2 million across 5 years, with a median of $1.8 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Operating Leases sank 46.44% in 2025, then soared 855.99% in 2026.
- A 5-year view of Operating Leases shows it stood at $665000.0 in 2022, then jumped by 236.39% to $2.2 million in 2023, then slumped by 31.92% to $1.5 million in 2024, then jumped by 763.49% to $13.2 million in 2025, then dropped by 3.54% to $12.7 million in 2026.
- The last three Operating Leases figures came in at $12.7 million (Q1 2026), $13.2 million (Q4 2025), and $918000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.69 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 665,000.00 |
| Dec 31, 2021 | 1.15 Mn |